SHPH · Shuttle Pharmaceuticals Holdings, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company’s existing cash resources, the cash received from the equity offerings, and financing available under the revolving note are not expected to provide sufficient funds to carry out the Company’s operations through the next twelve months. The ability of the Company to continue as a going concern is dependent upon its ability to continue to successfully raise additional equity or debt financing to allow it to fund ongoing operations, fund milestone and contingent payments due under the APA, and commercialize and market the Molecule.ai platform in order to generate revenues. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-14 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
82,116 |
| 2026-07-13 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
1,033 |
| 2026-07-10 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
731 |
| 2026-07-09 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
8,266 |
| 2026-07-08 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
18,531 |
| 2026-07-07 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
10,580 |
| 2026-07-06 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
9,022 |
| 2026-07-02 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
7,851 |
| 2026-07-01 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
3,959 |
| 2026-06-30 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
6,755 |
| 2026-06-29 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
25,836 |
| 2025-08-08 | Nabyt Oleh |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Restricted Stock Unit
|
29,240 |
| 2025-08-08 | Lorber Timothy J. |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Restricted Stock Unit
|
29,240 |
| 2025-08-08 | Tung Joseph |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Restricted Stock Unit
|
29,240 |
| 2025-08-08 | Richards Steven M |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Restricted Stock Unit
|
29,240 |
| 2025-08-08 | Scorsis George |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Restricted Stock Unit
|
29,240 |
| 2025-08-08 | Lorber Timothy J. |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. These RSUs will vest on 02/08/2026. |
Restricted Stock Unit
|
24,854 |
| 2024-12-23 | Schafer Joshua |
CCO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. |
Common Stock
|
209,790 |
| 2024-12-23 | Brown Milton |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting. |
Common Stock
|
209,790 |
| 2024-12-23 | Richards Steven M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. |
Common Stock
|
209,790 |
| 2024-05-01 | Jung Mira |
Chief Scientific Officer |
Award↓
Filing footnotes — CLASS A COMMON STOCK (Direct)
The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024. Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024. |
CLASS A COMMON STOCK
|
598 |
| 2024-03-08 | Vander Hoek Michael |
Chief Financial Officer |
Award↑
|
COMMON STOCK
|
100,000 |
| 2023-12-13 | Jacobs Bette |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions. |
Common Stock
|
4,157 |
| 2023-12-13 | Brown Milton |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of (i) 1,077,943 shares of common stock and (ii) 16,667 RSUs which remain subject to certain vesting conditions. |
Common Stock
|
2,921 |
| 2023-08-14 | Dritschilo Anatoly |
Director, CEO and Chairman, 10% Owner |
Gift↓
Filing footnotes — COMMON STOCK (Indirect)
Represents 2,100,000 shares held by the spouse of the Reporting Person, and over which the Reporting Person disclaims any beneficial ownership or control. Prior to the contribution, the Reporting Person's spouse held a total of 3,204,407 shares. On August 14, 2023, she contributed 2,100,000 shares to PAL Trust, a trust formed for the benefit of her adult children. Consists of 1,104,407 shares held by the spouse of the Reporting Person. The inclusion in this report of the 1,104,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
COMMON STOCK
(I)
|
2,100,000 |
| 2023-08-14 | Dritschilo Anatoly |
Director, CEO and Chairman, 10% Owner |
Gift↑
Filing footnotes — COMMON STOCK (Indirect)
Consists of 2,100,000 shares gifted by the Reporting Person's spouse to PAL Trust, a trust formed for the benefit of the Reporting Person's adult children and for which a third party serves as external trustee and two of the Reporting Person's children serve as co-trustees. Beneficial ownership is disclaimed except to the extent the Reporting Person's spouse maintains any pecuniary interest therein. The inclusion in this report of the 2,100,000 shares held by the trust for the benefit of the Reporting Person's adult children shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
COMMON STOCK
(I)
|
2,100,000 |
| 2023-02-15 | Brown Milton |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
The Reporting Person received 25,000 stock options ("Stock Options") to purchase shares of SHPH common stock on February 15, 2023, which Stock Options vest in full on the first anniversary of the date of grant. |
Stock Options
|
25,000 |
| 2022-12-29 | Brown Milton |
Director |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 1,072,531 shares of SHPH common stock. |
COMMON STOCK
|
995 |
| 2022-12-29 | Rich Tyvin |
Chief Medical Officer |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 3,843 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 2,429 shares of SHPH common stock. |
COMMON STOCK
|
1,414 |
| 2022-12-29 | Adkins William |
Insider |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust"). |
COMMON STOCK
|
995 |
| 2022-12-29 | Jacobs Bette |
Director |
Sell↓
Filing footnotes — CLASS A COMMON STOCK (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,862 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 7,496 shares of SHPH common stock and 23,725 RSUs, with each RSU representing the right to receive one share of SHPH common stock upon vesting, which RSUs remain subject to certain vesting conditions. |
CLASS A COMMON STOCK
|
4,366 |
| 2022-12-29 | Vander Hoek Michael |
Chief Financial Officer |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 3,852 shares of SHPH common stock. |
COMMON STOCK
|
2,243 |
| 2022-12-29 | Senanayake Chris |
Director |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,417 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 2,791 shares of SHPH common stock. |
COMMON STOCK
|
1,626 |
| 2022-12-29 | Dritschilo Anatoly |
Director, CEO and Chairman, 10% Owner |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 1,085,200 shares of common stock held directly by the Reporting Person. |
COMMON STOCK
|
8,372 |
| 2022-12-29 | Dritschilo Peter |
President and COO |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 10,380 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 6,560 shares of SHPH common stock. |
COMMON STOCK
|
3,820 |
| 2022-12-29 | Jung Mira |
Chief Scientific Officer |
Sell↓
Filing footnotes — CLASS A COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 892 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 1,071,388 shares of SHPH common stock. |
CLASS A COMMON STOCK
|
328 |
| 2022-12-29 | Richards Steven M |
Director |
Sell↓
Filing footnotes — COMMON STOCK (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 1,707 shares of SHPH common stock. |
COMMON STOCK
|
995 |
| 2022-09-02 | Adkins William |
Insider |
Other↑
Filing footnotes — WARRANTS (right to buy) (Direct)
Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering. |
WARRANTS (right to buy)
|
138,889 |